Skip to main content
Filing year 2024

LYSOSOMAL AND RARE DISORDERS RESEARCH AND TREATMENT CENTER INC

Fairfax, Virginia·EIN 45-5312680·NTEE H80 · Medical Research·501(c)(3)
Total revenue
$4.4M
Total assets
$2.4M
Total expenses
$3.7M
Reported officers
5
Mission

LYSOSOMAL AND RARE DISORDERS RESEARCH AND TREATMENT CENTER INC'S (LDRTC) MISSION IS TO PROVIDE RESEARCH TO UNRAVEL UNDERLYING DISEASE-CAUSING MECHANISMS, DISCOVER NEW BIOMARKERS AND EXPLORE NEW THERAPEUTIC PATHWAYS AND TREATMENT OPTIONS. FURTHER, LDRTC WORKS TO EDUCATE PATIENTS, FAMILIES, HEALTHCARE PROVIDERS AND RESEARCHERS IN THE FIELD. FINALLY, IT PROVIDES TREATMENT AND CLINICAL CARE TO PERSONS SUFFERING FROM LYSOSOMAL AND OTHER RARE DISEASES.

Executive compensation, broken down

Form 990 · Part VII & Schedule J · 5 reported individuals · Filing year 2024

Percentile bands compare each position's total pay with the same role at Medical Research organizations nationwide.

President / Founder
75th to 90th percentile
$327k
$348k
Base
$318k
Bonus
Other
Benefits
$9k
Dir. of Translational Research
Highest Compensated Employee
10th to 25th percentile
$136k
$144k
Director / Manager
Board Member
75th to 90th percentile
$127k
$135k
Treasurer / Operations Director
10th to 25th percentile
$116k
$123k
Secretary / LPN
Officer (Unspecified)
$88k
$94k

Teal figures restate each filed amount in 2026 dollars.

Estimated with Washington-Arlington-Alexandria, DC-VA-MD-WV metro-area CPI-U, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Browse compensation in Medical Research

Pay in context

Top pay as a share of expenses

In 2024, the highest total compensation at LYSOSOMAL AND RARE DISORDERS RESEARCH AND TREATMENT CENTER INC equaled 9% of the organization's total expenses. The median for medical research organizations is 10%.

This organization (2024)
9%
Sector median
10%
Middle half of sector
4% to 21%

Based on 1,118 medical research organizations, each measured at its most recent filing year with reported expenses and compensation.

Funded by

Private foundations whose Form 990-PF Part XV grants matched this organization.

Fell 14%
over 3 years

From $381k in 2021 to $327k in 2024.

$381k
2021
$305k
2022
$297k
2023
$327k
2024
In today's dollarsEst.
Down 24% in real terms$459k to $348k

Estimated with Washington-Arlington-Alexandria, DC-VA-MD-WV metro-area CPI-U, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Pay for the position

Chief Executive Officer pay fell 14% from 2021 to 2024, while revenue rose 66%.

$381k in 2021 to $327k in 2024.
  • Highest Compensated Employee pay rose 21% from 2023 to 2024.
  • Board Member pay rose 36% from 2021 to 2024.

Pay for the position itself, not any one person. The officeholder may have changed between 2021 and 2024.

Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

FAQ

Common questions about LYSOSOMAL AND RARE DISORDERS RESEARCH AND TREATMENT CENTER INC

What does the Chief Executive Officer of LYSOSOMAL AND RARE DISORDERS RESEARCH AND TREATMENT CENTER INC earn?

In 2024, the Chief Executive Officer of LYSOSOMAL AND RARE DISORDERS RESEARCH AND TREATMENT CENTER INC received $327,309 in total compensation. This pay is in the top quarter for Chief Executive Officer roles among Medical Research organizations nationwide, though not the top 10% of comparable filings. Based on IRS Form 990 data.

How does Chief Executive Officer pay at LYSOSOMAL AND RARE DISORDERS RESEARCH AND TREATMENT CENTER INC compare with similar nonprofits?

Compared with the same role at Medical Research organizations nationwide, the 2024 pay of the Chief Executive Officer at LYSOSOMAL AND RARE DISORDERS RESEARCH AND TREATMENT CENTER INC falls between the 75th and 90th percentiles. In 2024, the highest total compensation at LYSOSOMAL AND RARE DISORDERS RESEARCH AND TREATMENT CENTER INC equaled 9% of the organization's total expenses. The median for medical research organizations is 10%.

What are LYSOSOMAL AND RARE DISORDERS RESEARCH AND TREATMENT CENTER INC's revenue and expenses?

In 2024, LYSOSOMAL AND RARE DISORDERS RESEARCH AND TREATMENT CENTER INC reported $4.4M in total revenue and $3.7M in total expenses on its IRS Form 990.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.